海外のダヴィンチロボット支援下子宮摘出術のベスト医師 — ページ2

Seree Teerapong医師は、Intrarat病院でのロボット支援下子宮全摘出術を含む、低侵襲な婦人科手術を専門としています。

• タイ医療評議会による腹腔鏡下婦人科手術の認定医
• 生殖医療の学位を保持
• タイの主要な医療機関の一つであるSiriraj病院で研修

ステップファンスキー医師は、テルアビブ医療センター（イヒロフ）の腫瘍内科入院病棟を率いており、内科および腫瘍学を専門としています。

• 腫瘍学における26 年以上の経験
• 2015年より腫瘍内科入院病棟のディレクターを務める
• 臨床腫瘍学研究における主要および副研究者
• テルアビブ医療センター（イヒロフ）にて研修

ダン・グリサロ教授はイヒロフ・ソラスキー病院の婦人科腫瘍学部門を率いており、複雑な癌に対するロボット支援手術を専門としています。

• イヒロフ・ソラスキー病院 産婦人科部長
• トロント大学にて婦人科腫瘍学の研修を修了
• 婦人科癌に関する83本の科学論文を発表
• 米国およびイスラエル婦人科腫瘍学会会員

Dissatat Budhithada医師は、Intrarat病院にてDaVinciシステムを使用したロボット支援下子宮摘出術を専門としています。

• タイ屈指の医学部であるチュラロンコン大学で研修
• ラマティボディ病院にて産婦人科の学位を取得
• 女性の生殖医療および複雑な婦人科症例の専門家

血液腫瘍疾患の分子生物学研究の専門家であるフォックス博士は、最先端の治療法を患者ケアに取り入れています。

• BKZゾーリンゲン認定がんセンターの主任医師
• 化学療法、免疫療法、標的療法の専門家
• 遺伝学の有資格専門医
• ドイツおよびアメリカの腫瘍学会会員

Quirónsalud Marbellaの産婦人科部長であるブランコ・エラエス医師は、女性の健康と革新的なケアに重点を置く多職種チームを率いています。

• 人間味のある出産と低介入の産科ケアを専門とする
• 人間味のある帝王切開プロトコルの導入を推進
• 包括的ながん治療のための多職種乳腺ユニットを開発
• スペイン産婦人科学会会員

セヴリーヌ・イボラ医師は、シュタットリッヒェス・クリニクム・ゾーリンゲンの産婦人科部長を務め、ダヴィンチ・システムを用いたロボット支援手術の専門知識を有しています。

• 婦人科腫瘍学の認定医であり、ウロギネコロジー（女性泌尿器科）の追加資格を保有
• RWTH大学病院にて産科および周産期医療部門を管理
• ドイツ産婦人科学会の正会員
• 子宮摘出術や筋腫核出術を含む低侵襲手術を実施

アレムダル医師は、メディカルパーク・アンタルヤ病院コンプレックスにて、ダヴィンチロボットを用いた子宮摘出術を専門としています。

• アクデニズ大学にて腫瘍内科の研修を修了
• 内科および腫瘍学において_doctor_9570_年以上の経験
• アンタルヤの主要な病院コンプレックスに勤務

ミハイル・バナク医師は、ポンデラス・アカデミック病院にて、子宮内膜症の治療を中心とした複雑な婦人科病理学を専門としています。

• 個別化された治療計画を提供する産婦人科コンサルタント
• 包括的なケアのために多職種チームで連携
• 卓越性を追求する現代的な医療環境で診療

Na Young Bae医師は、ソウル・ミズ病院にてロボット支援婦人科手術を専門としており、低侵襲手術の技術において広範なトレーニングを受けています。

• 韓国大学医学部卒業
• 韓国大学医療センターにてレジデント修了
• 韓国婦人科内視鏡学会会員
• 腹腔鏡手術およびロボット手術の専門家

イェ・ジ・リー医師は、韓国のソウル・ミズ病院の産婦人科医です。子宮筋腫や卵巣嚢腫に対する低侵襲治療を専門としています。リー医師はソウル大学病院で臨床研修を修了しました。国際的な患者の診療を行っており、生物医学の修士号を取得しています。

• 心電図解析に人工知能を活用し、周産期心筋症の検出を行っています。
• 韓国母体胎児医学会の会員です。
• 「国境なき医師団」のボランティアとして、世界の女性の健康支援に取り組んでいます。
• 婦人科疾患の治療を年間1万件以上行うソウル・ミズ病院に勤務しています。

2つのロボットプラットフォームを使用して手術を行う認定をSERGSから世界で初めて受けた婦人科医。スタンチウ医師は、ポンデラス・アカデミック病院にて複雑な低侵襲手術を専門としています。

• 婦人科腫瘍学およびロボット手術のサブスペシャリスト
• ロイヤル・マーズデン病院およびその他の欧州トップセンターで研修
• 若年がん患者に対する妊孕性温存手術を実施
• 革新的な技術に関する多数の科学論文の著者
• ロボット手術および婦人科腫瘍学の国際認定医

ロイ・マシアフ医師は、イスラエルのシェバ医療センターの婦人科部長です。低侵襲婦人科手術および妊孕性温存手術を専門としています。マシアフ医師は、AAGLから外科的イノベーションに対するダニエル・F・コット賞を受賞しました。

• イスラエル婦人科内視鏡学会の会長を務める。
• フォーブス誌により、イスラエルのベストドクターに継続的に選出されている。
• 腹腔鏡下子宮摘出術およびロボット支援下筋腫摘出術を専門とする。
• 世界トップ10病院にランクされるシェバ医療センターに勤務。

ヤーコフ・ローレンス医師は、シェバ医療センターの放射線腫瘍科部長です。精密放射線治療と神経腫瘍学を専門としています。ローレンス医師は、膵臓がんの疼痛管理のための腹腔神経叢ラジオサージェリー（放射線外科）の先駆者です。専門分野における最高の名誉の一つであるFASTROの称号を保持しています。

• シェバ医療センターの消化器がんプログラムを主導。
• 脳腫瘍および神経系がんに対する定位放射線外科手術を実施。
• 個別化された放射線プロトコルに関する280以上の科学論文を執筆。
• トーマス・ジェファーソン大学で放射線腫瘍学のフェローシップ研修を修了。

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

_doctor_3603_年の経験を持つユトキン医師は、ハダッサ医療センターにて低侵襲手術を専門としています。

• エルサレム・ヘブライ大学医学部卒業
• 顎関節症の診断と治療に精通
• 英語、ヘブライ語、ロシア語に堪能で、国際的な患者に対応可能
• イスラエル有数の医療センターであるハダッサに勤務

ビルニ大学病院にて低侵襲ロボット支援下子宮全摘術を専門とし、婦人科腫瘍外科の高度なトレーニングを受けている。

• エルジイェス大学にて婦人科腫瘍外科のトレーニングを修了
• シャリテ・ベルリン医科大学にてがん外科手術の高度トレーニングを修了
• ロボット手術および低侵襲技術に注力
• 婦人科腫瘍学において豊富な経験を持つ准教授